Adlai Nortye Ltd.
ANLNASDAQHealthcare● Active
$9.74
$-0.21(-2.11%)
Market Cap$516999188
P/E Ratio—
52W High$17.25
52W Low$0.879
Adlai Nortye Ltd. (ANL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ANL · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 10, 2026EPS Actual
-$0.18
Est. -$0.10 · -71.4%
Revenue
$0.01B
Est. $0.01B · -47.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 10, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
ANL reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.00B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.00B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.14 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | Apr 10, 2026 | -$0.10 | -$0.18 | -71.4% | $0.01B | $0.01B | -47.0% |
| — Q4 FY2025 | Dec 29, 2025 | -$0.18 | -$0.18 | +0.0% | — | $0.00B | — |
| — Q3 FY2025 | Aug 7, 2025 | -$0.18 | -$0.18 | +0.0% | — | — | — |
| ▲ Q2 FY2025 | Apr 30, 2025 | -$0.53 | -$0.22 | +58.5% | — | — | — |
| ▲ Q1 FY2025 | Feb 26, 2025 | -$0.53 | -$0.22 | +58.5% | — | — | — |
| ▲ Q3 FY2024 | Aug 8, 2024 | -$1.06 | -$0.53 | +50.1% | $0.00B | — | — |
| ▼ Q2 FY2024 | Apr 20, 2024 | -$0.38 | -$0.65 | -70.5% | $0.00B | — | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.14
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 10, 2026Miss
EPS Actual
-$0.18
EPS Est.
-$0.10
EPS Surpr.
-71.4%
Revenue
$0.01B
Q4 FY2025
Dec 29, 2025
EPS Actual
-$0.18
EPS Est.
-$0.18
EPS Surpr.
+0.0%
Revenue
—
Q3 FY2025
Aug 7, 2025
EPS Actual
-$0.18
EPS Est.
-$0.18
EPS Surpr.
+0.0%
Revenue
—
Q2 FY2025
Apr 30, 2025Beat
EPS Actual
-$0.22
EPS Est.
-$0.53
EPS Surpr.
+58.5%
Revenue
—
Q1 FY2025
Feb 26, 2025Beat
EPS Actual
-$0.22
EPS Est.
-$0.53
EPS Surpr.
+58.5%
Revenue
—
Q3 FY2024
Aug 8, 2024Beat
EPS Actual
-$0.53
EPS Est.
-$1.06
EPS Surpr.
+50.1%
Revenue
$0.00B
Q2 FY2024
Apr 20, 2024Miss
EPS Actual
-$0.65
EPS Est.
-$0.38
EPS Surpr.
-70.5%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $-0.17 | $-0.17 | $-0.17 | 1 |
| Q4 FY2026 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q3 FY2026 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Q2 FY2026 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q1 FY2026 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q3 FY2025 | $-0.18 | $-0.18 | $-0.18 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 10, 2026 | -71.4% | $12.00 | $11.16 | -7.00% |
| ▲ Q4 FY2025 | Dec 29, 2025 | +0.0% | $1.64 | $1.80 | +9.76% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +0.0% | $1.55 | $1.55 | +0.00% |
| ▲ Q2 FY2025 | Apr 30, 2025 | +58.5% | $1.98 | $1.84 | -7.07% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +58.5% | $2.15 | $2.22 | +3.26% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +50.1% | $3.08 | $3.14 | +1.95% |
| ▼ Q2 FY2024 | Apr 20, 2024 | -70.5% | $12.40 | $14.42 | +16.29% |
| — Q1 FY2024 | Mar 31, 2024 | — | $8.88 | $9.40 | +5.86% |
Q2 FY2026-7.00%
Report Date
Apr 10, 2026
EPS Beat/Miss
-71.4%
Price Before
$12.00
Price After
$11.16
Q4 FY2025+9.76%
Report Date
Dec 29, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.64
Price After
$1.80
Q3 FY2025+0.00%
Report Date
Aug 7, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.55
Price After
$1.55
Q2 FY2025-7.07%
Report Date
Apr 30, 2025
EPS Beat/Miss
+58.5%
Price Before
$1.98
Price After
$1.84
Q1 FY2025+3.26%
Report Date
Feb 26, 2025
EPS Beat/Miss
+58.5%
Price Before
$2.15
Price After
$2.22
Q3 FY2024+1.95%
Report Date
Aug 8, 2024
EPS Beat/Miss
+50.1%
Price Before
$3.08
Price After
$3.14
Q2 FY2024+16.29%
Report Date
Apr 20, 2024
EPS Beat/Miss
-70.5%
Price Before
$12.40
Price After
$14.42
Q1 FY2024+5.86%
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
$8.88
Price After
$9.40
Avg Beat Reaction+1.58%
Avg Miss Reaction+4.64%
Beat Rate5 / 8 quarters
Largest Move+16.29% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ANL ends December
Adlai Nortye Ltd. (ANL) most recently reported earnings on April 10, 2026 for Q2 FY2026, posting EPS of $-0.18 — missing the analyst consensus of $-0.10 by -71.4%. The next ANL earnings date is expected around September 1, 2026.
Each quarter, investors track ANL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ANL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ANL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ANL earnings · 5 questionsAdlai Nortye Ltd.'s next earnings report is expected around September 1, 2026. ANL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ANL historically reports after market close (AMC).
ANL earnings datewhen is ANL earningsANL next earnings datewhen does ANL report earningsANL earnings calendar
▸ Source: FMP · Adlai Nortye Ltd. SEC filings · US GAAP · Adlai Nortye Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026